← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2015Last known activity
Oct 27, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (42 distinct, 26 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Recent trials (29)
- NCT06968806CollaboratorPhase 3Oct 27, 2025
- NCT07153744CollaboratorPhase 4Sep 1, 2025
- NCT07115550Lead sponsorN/AAug 26, 2025
- NCT06936488Lead sponsorN/AMar 1, 2025
- NCT06762782CollaboratorPhase 2Feb 28, 2025
- NCT06566807Lead sponsorPhase 2Aug 25, 2024
- NCT06538883CollaboratorN/AAug 1, 2024
- NCT06232694CollaboratorN/AJan 1, 2024
- NCT07065435CollaboratorPhase 2Jan 1, 2024
- NCT06254690CollaboratorPhase 2Jan 1, 2024
- NCT06445257Lead sponsorN/ASep 15, 2023
- NCT05909293CollaboratorN/AApr 12, 2023
- NCT05491811CollaboratorPhase 2Aug 31, 2022
- NCT06328179Lead sponsorN/AMay 24, 2022
- NCT06172998Sponsor investigatorEarly Phase 1Apr 1, 2022
Details
- Founded
- Huai'an, CN
- Last known activity
- Oct 27, 2025